Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Traditional Chinese Medicine Holdings Co ( (HK:0570) ) has issued an announcement.
China Traditional Chinese Medicine Holdings Co. Limited announced the retirement of Ernst & Young as its auditor due to regulatory requirements limiting the tenure of auditing firms for state-owned enterprises. The company assured stakeholders that this change will not impact its financial reporting for the year ending December 2025 and is actively seeking a new auditor.
The most recent analyst rating on (HK:0570) stock is a Buy with a HK$5.00 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited operates in the traditional Chinese medicine industry, focusing on the production and distribution of herbal medicines and related healthcare products. The company is a subsidiary of China National Pharmaceutical Group Co., Ltd., a central state-owned enterprise in China.
Average Trading Volume: 35,517,723
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.08B
Learn more about 0570 stock on TipRanks’ Stock Analysis page.